| 1.61 0.01 (0.63%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.25  |
1-year : | 2.54 |
| Resists | First : | 1.92 |
Second : | 2.18 |
| Pivot price | 1.69 |
|||
| Supports | First : | 1.51 |
Second : | 1.26 |
| MAs | MA(5) : | 1.62 |
MA(20) : | 1.7 |
| MA(100) : | 1.55  |
MA(250) : | 2.01 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 20.4 |
D(3) : | 28.3 |
| RSI | RSI(14): 42 |
|||
| 52-week | High : | 3.76 | Low : | 0.62 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AIFF ] has closed above bottom band by 16.8%. Bollinger Bands are 70.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.68 - 1.69 | 1.69 - 1.7 |
| Low: | 1.5 - 1.51 | 1.51 - 1.52 |
| Close: | 1.6 - 1.61 | 1.61 - 1.62 |
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Tue, 02 Jun 2026
Firefly Neuroscience Identifies Novel Biomarker for PTSD in Partnership with U.S. Department of War - Quiver Quantitative
Tue, 02 Jun 2026
AI brain scans reveal PTSD signal as U.S. faces $232B cost - Stock Titan
Mon, 18 May 2026
AIFF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Wed, 13 May 2026
AIFF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wed, 22 Apr 2026
Firefly Neuroscience raises $8 million in additional private placement - Investing.com
Tue, 31 Mar 2026
Firefly Neuroscience 2025 10-K: Revenue $1.14M, EPS not disclosed - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 1.358e+007 (%) |
| Held by Institutions | 28 (%) |
| Shares Short | 1,310 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.38e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -414.5 % |
| Return on Assets (ttm) | -45.7 % |
| Return on Equity (ttm) | -131.5 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 0.04 |
| Sales Per Share | 0.07 |
| EBITDA (p.s.) | -0.58 |
| Qtrly Earnings Growth | -0.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 20.88 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 913070 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|